Skip to content

Clinical trials

Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Clear all

890 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
200110
20029
200310
200416
200518
200633
200723
200822
200921
201032
201124
201220
201320
201430
201531
201628
201743
201838
201946
202040
202146
202254
202358
202459
202573
202650

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed524
Unknown status116
Recruiting107
Terminated45
Not yet recruiting40
Active, not recruiting22
Withdrawn20
Enrolling by invitation10
Suspended6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline39
National Institute of Mental Health (NIMH)26
VA Office of Research and Development14
Sanofi13
Stanford University13
Ludwig-Maximilians - University of Munich11
New York State Psychiatric Institute11
University of Oxford10
Massachusetts General Hospital9
University of Pittsburgh9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder890
Major Depressive Disorder215
Anxiety Disorders205
Mood Disorders103
Bipolar Disorder82
Mental Disorders81
Depressive Disorder, Treatment-Resistant43
Stress Disorders, Post-Traumatic33
Schizophrenia26
Psychotic Disorders22

Trials

Showing 76 to 100 of 890. Each trial links to its page on Pharma Observatory.

790 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.